Search

Your search keyword '"Samuel S Lee"' showing total 511 results

Search Constraints

Start Over You searched for: Author "Samuel S Lee" Remove constraint Author: "Samuel S Lee"
511 results on '"Samuel S Lee"'

Search Results

3. Rituximab for the Treatment of Patients with Autoimmune Hepatitis Who are Refractory or Intolerant to Standard Therapy

5. Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy

6. Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.

7. Impact of Pharmaceutical Industry Versus University Sponsorship on Survey Response: A Randomized Trial among Canadian Hepatitis C Care Providers

8. Emergency Management of Bleeding Esophageal Varices: Drugs, Bands or Sleep?

9. Acute Management and Secondary Prophylaxis of Esophageal Variceal Bleeding: A Western Canadian Survey

11. Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up.

12. Reactivation of Hepatitis B e Antigen-Negative Chronic Hepatitis B in a Bone Marrow Transplant Recipient following Lamivudine Withdrawal

13. Hemodynamic Characterization of Arterialized and Nonarterialized Liver Transplants in the Rat

14. Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis

16. Chronic Hepatitis C in Western Canada: A Survey of Practice Patterns among Gastroenterologists in Alberta and British Columbia

17. Hepatitis C Diagnosis and Treatment Among Indigenous People in a Canadian Context: Challenges and Community-Led Solutions

18. Brain-specific rescue of Clock reveals system-driven transcriptional rhythms in peripheral tissue.

19. Failure of Splenectomy to Ameliorate Portal Hypertension in Myeloproliferative Disorders

20. Fatal Hepatic Decompensation in a Patient with Hepatitis B Cirrhosis Following Famciclovir Withdrawal

21. Autonomic Regulation of Splanchnic Circulation

22. Second-Line Treatment after Failure of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Tyrosine Kinase Inhibitor, Retrial of Immunotherapy, or Locoregional Therapy?

25. Acute Coinfection with Hepatitis B and Hepatitis C Viruses

26. Vasopressin Antagonists and Dilutional Hyponatremia

29. Cardiomyopathy in cirrhosis: From pathophysiology to clinical careKey points

31. Prolonged QT Interval in Cirrhosis: Twisting Time?

32. Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy

33. Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy

35. Impact of direct‐acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings

37. Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension

39. Impact of the COVID-19 Pandemic on Hospitalizations for Alcoholic Hepatitis or Cirrhosis in Alberta, Canada

40. Patient‐specific genetic factors predict treatment failure in sofosbuvir‐treated patients with chronic hepatitis C

44. A real-world retrospective single-centre study of the cost-effectiveness and long-term outcomes of pegylated interferon for chronic hepatitis B

49. List of contributors

Catalog

Books, media, physical & digital resources